CD79A and COVID-19: The GOLD ELISA COVID-19 IgG/IgM was the first test to detect seroconversion at 4–5 days post symptom onset, followed by the IBMP Spike IgA/IgM/IgG ELISA on day 6, the Anti-SARS-CoV-2 IgG ELISA on day 7, and the Anti-SARS-CoV-2 IgM ELISA on day 9 post symptom onset.